Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 158.363 | 81 |
GSM780708 | Untreated after 4 days (C2_1) | 191.021 | 83 |
GSM780709 | Untreated after 4 days (C3_1) | 177.709 | 82 |
GSM780719 | Untreated after 4 days (C1_2) | 156.943 | 81 |
GSM780720 | Untreated after 4 days (C2_2) | 195.672 | 83 |
GSM780721 | Untreated after 4 days (C3_2) | 174.395 | 82 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 204.832 | 84 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 171.677 | 82 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 193.815 | 83 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 192.594 | 83 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 173.928 | 82 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 170.901 | 82 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 124.866 | 78 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 186.383 | 83 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 168.863 | 82 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 129.435 | 79 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 196.176 | 83 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 156.927 | 81 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 126.812 | 78 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 123.637 | 78 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 183.052 | 83 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 111.712 | 77 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 157.917 | 81 |